Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of thrombotic disorders
3.2.1.2 Rising number of surgical procedures
3.2.1.3 Advancements in drug development and technology
3.2.1.4 Growing emphasis on preventive healthcare
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with thrombosis drugs
3.2.2.2 Risk of adverse reactions and side effects
3.3 Growth potential analysis
3.4 Porter’s analysis
3.5 PESTEL analysis
3.6 Regulatory landscape
3.7 Technological landscape
3.8 Reimbursement scenario
3.9 Pricing analysis, 2023
3.10 Future market trends
3.11 Gap analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Anticoagulants
5.2.1 Direct oral anticoagulants
5.2.2 Heparin
5.2.3 Vitamin K antagonists
5.2.4 Xa Inhibitor
5.3 Antiplatelet drugs
5.3.1 P2Y12 platelet inhibitor
5.3.2 Aspirin
5.3.3 Glycoprotein IIb/IIIa inhibitors
5.4 Thrombolytic drugs
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Venous thromboembolism
6.3 Deep vein thrombosis
6.4 Pulmonary embolism
6.5 Arterial thrombosis
6.6 Other disease types
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Parenteral
7.4 Topical
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospital pharmacies
8.3 Retail pharmacies
8.4 Online pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Amgen Inc.
10.2 Aspen Pharmacare Holdings Limited
10.3 Baxter International Inc.
10.4 Bayer AG
10.5 Boehringer Ingelheim GmbH
10.6 Bristol-Myers Squibb Company
10.7 Daiichi Sankyo Company, Limited
10.8 GlaxoSmithKline plc
10.9 Janssen Pharmaceuticals, Inc.
10.10 Novartis AG
10.11 Pfizer Inc.
10.12 Sanofi
